Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   testicular germ cell tumor
  

Disease ID 1099
Disease testicular germ cell tumor
Definition
A germ cell tumor arising from the testis. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor.
Synonym
germ cell neoplasm of testis
germ cell neoplasm of the testis
germ cell tumor of testis
germ cell tumor of testis (disorder)
germ cell tumor of the testis
germ cell tumour of testis
male germ cell tumor
mgct
testicular germ cell neoplasm
testicular germ cell neoplasms
tgct
Orphanet
OMIM
DOID
UMLS
C1336708
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:10)
C0014130  |  hormonal imbalance  |  1
C0007099  |  carcinoma in situ  |  1
C0206661  |  gonadoblastoma  |  1
C0008625  |  chromosomal abnormality  |  1
C0037856  |  testicular torsion  |  1
C0686619  |  lymph node metastases  |  1
C0153687  |  skin metastases  |  1
C0206093  |  primitive neuroectodermal tumor  |  1
C0036631  |  seminoma  |  1
C0206093  |  neuroectodermal tumors  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:23)
2261  |  FGFR3  |  UNIPROT
3815  |  KIT  |  CTD_human
1761  |  DMRT1  |  GWASCAT
5307  |  PITX1  |  CTD_human;GWASCAT
6928  |  HNF1B  |  GWASCAT
4254  |  KITLG  |  GWASCAT;ORPHANET
55159  |  RFWD3  |  CTD_human;GWASCAT
81848  |  SPRY4  |  ORPHANET
1062  |  CENPE  |  GWASCAT
8379  |  MAD1L1  |  CTD_human;GWASCAT
6794  |  STK11  |  CTD_human;UNIPROT
9534  |  ZNF254  |  GWASCAT
63978  |  PRDM14  |  CTD_human;GWASCAT
9673  |  SLC25A44  |  GWASCAT
4313  |  MMP2  |  CTD_human
101927688  |  SEPT4-AS1  |  GWASCAT
578  |  BAK1  |  GWASCAT
55729  |  ATF7IP  |  GWASCAT
8888  |  MCM3AP  |  GWASCAT
7371  |  UCK2  |  GWASCAT
1618  |  DAZL  |  CTD_human
27306  |  HPGDS  |  CTD_human;GWASCAT
6793  |  STK10  |  UNIPROT
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:24)
578  |  BAK1  |  CIPHER
1312  |  COMT  |  CIPHER
1588  |  CYP19A1  |  CIPHER
1543  |  CYP1A1  |  CIPHER
1544  |  CYP1A2  |  CIPHER
1545  |  CYP1B1  |  CIPHER
2099  |  ESR1  |  CIPHER
2100  |  ESR2  |  CIPHER
3292  |  HSD17B1  |  CIPHER
3295  |  HSD17B4  |  CIPHER
4254  |  KITLG  |  CIPHER
81848  |  SPRY4  |  CIPHER
6817  |  SULT1A1  |  CIPHER
6783  |  SULT1E1  |  CIPHER
5307  |  PITX1  |  CTD_human
55159  |  RFWD3  |  CTD_human
8379  |  MAD1L1  |  CTD_human
63978  |  PRDM14  |  CTD_human
6794  |  STK11  |  CTD_human
3815  |  KIT  |  CTD_human
4313  |  MMP2  |  CTD_human
1618  |  DAZL  |  CTD_human
27306  |  HPGDS  |  CTD_human
8093  |  MGCT  |  CTD_human
Text Mined Gene(Waiting for update.)
Locus(Waiting for update.)
Disease ID 1099
Disease testicular germ cell tumor
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:10)
HP:0002664  |  Neoplasia  |  3
HP:0000028  |  Cryptorchidism  |  2
HP:0012215  |  Testicular microlithiasis  |  2
HP:0001061  |  Acne  |  1
HP:0002716  |  Lymph node hyperplasia  |  1
HP:0000078  |  Genital abnormalities  |  1
HP:0030731  |  Carcinoma  |  1
HP:0100813  |  Testicular torsion  |  1
HP:0030065  |  Primitive neuroectodermal tumor  |  1
HP:0000150  |  Gonadoblastoma  |  1
Disease ID 1099
Disease testicular germ cell tumor
Manually Symptom
UMLS  | Name(Total Manually Symptoms:12)
C1828448  |  paraneoplastic encephalitis
C0555278  |  cerebral metastasis
C0220650  |  brain metastases
C0206663  |  primitive neuroectodermal tumors
C0206659  |  embryonal carcinoma
C0153690  |  bone metastasis
C0153677  |  mediastinal metastasis
C0153676  |  pulmonary metastasis
C0153676  |  pulmonary metastases
C0027663  |  multiple primary neoplasms
C0014145  |  yolk sac tumor
C0008626  |  chromosomal abnormality
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:2)
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:45)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs12699477236662398379MAD1L1umls:C1336708GWASCATIn the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.0.2402714422013MAD1L171929317TC
rs1508595194836814254KITLGumls:C1336708GAD[KITLG, encoding the ligand for the receptor tyrosine kinase KIT, which has previously been implicated in the pathogenesis of TGCT and the biology of germ cells, may explain the association on chromosome 12.]0.2434527992009NA1288592239GA
rs1695197415692944GSTM1umls:C1336708BeFreeGermline deletion polymorphisms in the glutathione S-transferase mu 1 (GSTM1) and the GST theta 1 (GSTT1), and a functional single nucleotide polymorphism in GST pi 1 (GSTP1, Ile105Val), were analyzed in TGCT survivors (TCSs) (n = 675) and controls (n = 189).0.0002714422009GSTP11167585218AG
rs1695197415692952GSTT1umls:C1336708BeFreeGermline deletion polymorphisms in the glutathione S-transferase mu 1 (GSTM1) and the GST theta 1 (GSTT1), and a functional single nucleotide polymorphism in GST pi 1 (GSTP1, Ile105Val), were analyzed in TGCT survivors (TCSs) (n = 675) and controls (n = 189).0.0002714422009GSTP11167585218AG
rs169519741569373156GSTK1umls:C1336708BeFreeGermline deletion polymorphisms in the glutathione S-transferase mu 1 (GSTM1) and the GST theta 1 (GSTT1), and a functional single nucleotide polymorphism in GST pi 1 (GSTP1, Ile105Val), were analyzed in TGCT survivors (TCSs) (n = 675) and controls (n = 189).0.0002714422009GSTP11167585218AG
rs169519741569133482SLCO6A1umls:C1336708BeFreeGermline deletion polymorphisms in the glutathione S-transferase mu 1 (GSTM1) and the GST theta 1 (GSTT1), and a functional single nucleotide polymorphism in GST pi 1 (GSTP1, Ile105Val), were analyzed in TGCT survivors (TCSs) (n = 675) and controls (n = 189).0.0002714422009GSTP11167585218AG
rs170214632366623927306HPGDSumls:C1336708GWASCATIn the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.0.2405428842013HPGDS494303661TG
rs2072499236662409673SLC25A44umls:C1336708GWASCATIdentification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.0.122013SLC25A441156199819AG
rs2072499258772999673SLC25A44umls:C1336708GWASCATTwo new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.0.122015SLC25A441156199819AG
rs21013823666239578BAK1umls:C1336708GWASCATMeta-analysis identifies four new loci associated with testicular germ cell tumor.0.1226384742013BAK1633574761AG
rs21013823666240578BAK1umls:C1336708GWASCATIdentification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.0.1226384742013BAK1633574761AG
rs21013819483681578BAK1umls:C1336708GWASCATA genome-wide association study of testicular germ cell tumor.0.1226384742009BAK1633574761AG
rs21013819483681578BAK1umls:C1336708GAD[A genome-wide association study of testicular germ cell tumor.]0.1226384742009BAK1633574761AG
rs2195987258772999534ZNF254umls:C1336708GWASCATTwo new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.0.122015NA1923966743CT
rs2720460258772991062CENPEumls:C1336708GWASCATTwo new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.0.122015CENPE4103133529AG
rs2720460236662401062CENPEumls:C1336708GWASCATIdentification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.0.122013CENPE4103133529AG
rs2839186236662408888MCM3APumls:C1336708GWASCATIdentification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.0.122013MCM3AP2146270154CT
rs29003332366624055729ATF7IPumls:C1336708GWASCATIdentification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.0.1202714422013ATF7IP1214500933CT
rs3790672236662407371UCK2umls:C1336708GWASCATIdentification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.0.1202714422013UCK21165904155TC
rs3790672258772997371UCK2umls:C1336708GWASCATTwo new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.0.1202714422015UCK21165904155TC
rs3805663236662405307PITX1umls:C1336708GWASCATFurthermore, PITX1, at 5q31.1, regulates TERT expression and is the third TGCT-associated locus implicated in telomerase regulation.0.2402714422013PITX15135030510AG
rs46248201948368181848SPRY4umls:C1336708GAD[A genome-wide association study of testicular germ cell tumor.]0.1226384742009NA5142302223GA
rs48882622366623955159RFWD3umls:C1336708GWASCATIn the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.0.2402714422013RFWD31674636560CT
rs70101622366624063978PRDM14umls:C1336708GWASCATIdentification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.0.242013PRDM14870064270CT
rs72212742366623927306HPGDSumls:C1336708BeFreeIn the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.0.2405428842013PPM1E1758930767AG
rs7221274236662398379MAD1L1umls:C1336708BeFreeIn the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.0.2402714422013PPM1E1758930767AG
rs722127423666239132160PPM1Mumls:C1336708BeFreeIn the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.0.0002714422013PPM1E1758930767AG
rs72212742366623956155TEX14umls:C1336708BeFreeIn the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.0.0002714422013PPM1E1758930767AG
rs7221274236662395889RAD51Cumls:C1336708BeFreeIn the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.0.0002714422013PPM1E1758930767AG
rs72212742366623955159RFWD3umls:C1336708BeFreeIn the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.0.2402714422013PPM1E1758930767AG
rs7501939258772996928HNF1Bumls:C1336708GWASCATTwo new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.0.122015HNF1B1737741165CT
rs755383236662401761DMRT1umls:C1336708GWASCATIdentification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.0.1208143262013DMRT19863635CT
rs755383236662391761DMRT1umls:C1336708GWASCATMeta-analysis identifies four new loci associated with testicular germ cell tumor.0.1208143262013DMRT19863635CT
rs99057042366623927306HPGDSumls:C1336708BeFreeIn the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.0.2405428842013SEPT4-AS11758555182GT
rs9905704236662398379MAD1L1umls:C1336708BeFreeIn the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.0.2402714422013SEPT4-AS11758555182GT
rs9905704236662395889RAD51Cumls:C1336708BeFreeIn the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.0.0002714422013SEPT4-AS11758555182GT
rs99057042366623956155TEX14umls:C1336708BeFreeIn the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.0.0002714422013SEPT4-AS11758555182GT
rs990570423666239132160PPM1Mumls:C1336708BeFreeIn the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.0.0002714422013SEPT4-AS11758555182GT
rs990570423666240101927688SEPT4-AS1umls:C1336708GWASCATIdentification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.0.122013SEPT4-AS11758555182GT
rs99057042366623955159RFWD3umls:C1336708BeFreeIn the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.0.2402714422013SEPT4-AS11758555182GT
rs990570423666239101927688SEPT4-AS1umls:C1336708GWASCATMeta-analysis identifies four new loci associated with testicular germ cell tumor.0.122013SEPT4-AS11758555182GT
rs995030194836814254KITLGumls:C1336708GWASCATKITLG, encoding the ligand for the receptor tyrosine kinase KIT, which has previously been implicated in the pathogenesis of TGCT and the biology of germ cells, may explain the association on chromosome 12.0.2434527992009KITLG1288496894AG
rs995030236662404254KITLGumls:C1336708GWASCATIdentification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.0.2434527992013KITLG1288496894AG
rs995030236662394254KITLGumls:C1336708GWASCATMeta-analysis identifies four new loci associated with testicular germ cell tumor.0.2434527992013KITLG1288496894AG
rs995030194836814254KITLGumls:C1336708GAD[KITLG, encoding the ligand for the receptor tyrosine kinase KIT, which has previously been implicated in the pathogenesis of TGCT and the biology of germ cells, may explain the association on chromosome 12.]0.2434527992009KITLG1288496894AG
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Disease ID 1099
Disease testicular germ cell tumor
Case(Waiting for update.)